Roberts, H. J.
December 1968
Angiology;Dec1968, Vol. 19 Issue 11, p652
Academic Journal
The article focuses on the massive diet fat-heart and coronary drug. It informs that if these programs are allowed to proceed according to their present research designs, and result in unjustified confusions referable to the dietary and pharmacologic treatment or prevention of ischemic heart disease, they will invite serious public health and economic consequences for the nation. It also informs that one relates to a 5-year nationwide study aimed at conclusively establishing the relationship between dietary cholesterol and saturated-unsaturated fat intake, the serum cholesterol-lipid concentrations and the incidence of cardiovascular complications in hypercholestoremic and other high-risk individuals.


Related Articles

  • Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial---Lipid Lowering Arm (ASCOT-LLA): A Multicentre Randomised Controlled Trial Sever, Peter S; Dahlöf, Björn; Poulter, Neil R; Wedel, Hans; Beevers, Gareth; Caulfield, Mark; Collins, Rory; Kjeldsen, Sverre E; Kristinsson, Arni; McInnes, Gordon T; Mehlsen, Jesper; Nieminen, Markku; O'Brien, Eoin; Östergren, Jan // Drugs;2004 Supplement 2, Vol. 64, p43 

    Background The lowering of cholesterol concentrations in individuals at high risk of cardiovascular disease improves outcome. No study, however, has assessed benefits of cholesterol lowering in the primary prevention of coronary heart disease (CHD) in hypertensive patients who are not...

  • Levels of Risk Factors Associated with Heart Attacks. Vasan, R. S.; Sullivan, L. M.; Wilson, P. W. F.; Sempos, C. T.; Sundström, J.; Kannel, W. B.; Levy, D.; D'Agostino, R. B. // Annals of Internal Medicine;3/15/2005, Vol. 142 Issue 6, pI23 

    The article focuses on the levels of risk factors associated with heart attacks. In the United States, coronary heart disease (CHD) is the most common cause of death and disability in middle-aged and older men and women. Coronary heart disease blocks the flow of blood through the arteries of the...

  • Wine Consumption and Other Dietary Variables in Males Under 60 Before and After Acute Myocardial Infarction. Cleophas, Ton J. M.; Tuinenberg, Ellen; van der Meulen, Jan; Zwinderman, Koos H. // Angiology;Aug1996, Vol. 47 Issue 8, p789 

    In France there are few cardiac deaths in spite of high animal fat intake. France and Italy have the highest overall intake of alcohol in the world. Obviously, there is an inverse association between coronary heart disease (CHD) and alcohol intake in these countries. Although in the past decade...

  • Cholesterol-induced stimulation of platelet aggregation is prevented by a hempseed-enriched diet. Prociuk, M.A.; Edel, A.L.; Richard, M.N.; Gavel, N.T.; Ander, B.P.; Dupasquier, C.M.C.; Pierce, G.N. // Canadian Journal of Physiology & Pharmacology;Apr2008, Vol. 86 Issue 4, p153 

    Hypercholesterolemia indirectly increases the risk for myocardial infarction by enhancing the ability of platelets to aggregate. Diets enriched with polyunsaturated fatty acids (PUFAs) have been shown to reduce the detrimental effects of cholesterol on platelet aggregation. This study...

  • Statin treatment for CHD. Newson, Louise // GP: General Practitioner;4/20/2007, p49 

    The article presents information related to the use of statins in the treatment of coronary heart disease (CHD). In Great Britain, it is estimated that cholesterol levels greater than 5.2mmol/l are a contributory factor in 46 per cent of CHD deaths. There is overwhelming evidence that statins...

  • Primary Prevention and Coronary Heart Disease: The Economic Benefits of Lowering Serum Cholesterol. Oster, Gerry; Epstein, Arnold M. // American Journal of Public Health;Jun86, Vol. 76 Issue 6, p647 

    We examined the expected economic benefits of cholesterol lowering for adult men with significant elevations of total serum cholesterol (above 260 mg/dl), incorporating estimates of direct benefits from anticipated reductions in lifetime expenditures for medical care, and estimates of indirect...

  • The Effects of Calcium Supplement on Serum Lipoprotein in Obese Adults Receiving Energy Restricted Diet. Shalileh, M.; Shidfar, F.; Eghtesadi, S. H.; Haghani, H.; Heidari, I. // Iranian Journal of Public Health;2009, Vol. 38 Issue 4, p10 

    Background: Coronary heart disease is one of the most important problems of public health. One risk factor is dyslipidemia. Evidence from molecular and animal research and epidemiologic investigations indicate that calcium intake may influence lipid metabolism.But intervention studies have...

  • Composition of LDL particle discriminates between hypercholesterolaemic persons with and without symptoms of coronary heart disease. Van Jaarsveld, Henretha; Pool, Gertruida F; Bester, Catharina J // Annals of Clinical Biochemistry;May2004, Vol. 41 Issue 3, p213 

    Background: It is well known that high total and LDL cholesterol concentrations are not prerequisites for ischemic heart disease. This study aimed to differentiate between patients with coronary heart symptoms and healthy subjects with high cholesterol concentrations, using other potential risk...

  • HNF4α is a Crucial Modulator of the Cholesterol-Dependent Regulation of NPC1L1. Yuki Iwayanagi; Tappei Takada; Hiroshi Suzuki // Pharmaceutical Research;May2008, Vol. 25 Issue 5, p1134 

    Abstract Purpose  Niemann-Pick C1-like 1 (NPC1L1) has been identified as a target of ezetimibe and found to be responsible for intestinal cholesterol absorption. Although, it was recently demonstrated that sterol responsive element binding protein 2 (SREBP2) is responsible for the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics